These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 28459037)

  • 1. Levosulpiride and Serum Prolactin Levels.
    Kuchay MS; Mithal A
    Indian J Endocrinol Metab; 2017; 21(2):355-358. PubMed ID: 28459037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antipsychotic-drug-induced hyperprolactinemia: physiopathology, clinical features and guidance].
    Besnard I; Auclair V; Callery G; Gabriel-Bordenave C; Roberge C
    Encephale; 2014 Feb; 40(1):86-94. PubMed ID: 23928066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review article: clinical implications of enteric and central D2 receptor blockade by antidopaminergic gastrointestinal prokinetics.
    Tonini M; Cipollina L; Poluzzi E; Crema F; Corazza GR; De Ponti F
    Aliment Pharmacol Ther; 2004 Feb; 19(4):379-90. PubMed ID: 14871277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacotoxicological aspects of levosulpiride.
    Rossi F; Forgione A
    Pharmacol Res; 1995 Feb; 31(2):81-94. PubMed ID: 7596959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5-HT4 receptors contribute to the motor stimulating effect of levosulpiride in the guinea-pig gastrointestinal tract.
    Tonini M; De Giorgio R; Spelta V; Bassotti G; Di Nucci A; Anselmi L; Balestra B; De Ponti F
    Dig Liver Dis; 2003 Apr; 35(4):244-50. PubMed ID: 12801035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipopolysaccharide- and tumor necrosis factor-alpha-induced changes in prolactin secretion and dopaminergic activity in the hypothalamic-pituitary axis.
    De Laurentiis A; Pisera D; Caruso C; Candolfi M; Mohn C; Rettori V; Seilicovich A
    Neuroimmunomodulation; 2002; 10(1):30-9. PubMed ID: 12207161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of mesulergine on prolactin secretion and dopamine D2 receptors-adaptive changes in diethylstilbestrol-induced hyperplasia of the rat anterior pituitary.
    Pisarek H; Stepien H; Pawlikowski M
    Endocr Regul; 1992 Mar; 26(1):17-22. PubMed ID: 1421203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Etiological Profile of Galactorrhoea.
    Atluri S; Sarathi V; Goel A; Boppana R; Shivaprasad C
    Indian J Endocrinol Metab; 2018; 22(4):489-493. PubMed ID: 30148095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Misleading diagnosis of hyperprolactinemia in women].
    Paepegaey AC; Veron L; Wimmer MC; Christin-Maitre S
    Gynecol Obstet Fertil; 2016 Mar; 44(3):181-6. PubMed ID: 26966035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of dopamine d2 receptor agonists in a pituitary transplantation-induced hyperprolactinaemia/anovulation model in rats.
    Moro M; Inada Y; Miyata H; Komatsu H; Kojima M; Tsujii H
    Clin Exp Pharmacol Physiol; 2001 Aug; 28(8):651-8. PubMed ID: 11473532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Time course of the changes in antipsychotic-induced hyperprolactinemia following the switch to aripiprazole.
    Lu ML; Shen WW; Chen CH
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Dec; 32(8):1978-81. PubMed ID: 18848860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of stress-induced and stimulated hyperprolactinemia with the group II metabotropic glutamate receptor selective agonist, LY379268.
    Johnson MP; Chamberlain M
    Neuropharmacology; 2002 Oct; 43(5):799-808. PubMed ID: 12384165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of levosulpiride in patients with functional dyspepsia accompanied by delayed gastric emptying.
    Song CW; Chun HJ; Kim CD; Ryu HS; Choe JG; Hyun JH
    Korean J Intern Med; 1998 Feb; 13(1):15-21. PubMed ID: 9538626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of acute and chronic levosulpiride administration on gastric tone and perception in functional dyspepsia.
    Distrutti E; Fiorucci S; Hauer SK; Pensi MO; Vanasia M; Morelli A
    Aliment Pharmacol Ther; 2002 Mar; 16(3):613-22. PubMed ID: 11876717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pituitary production of prolactin and prolactin-suppressing drugs.
    Tansey MJ; Schlechte JA
    Lupus; 2001; 10(10):660-4. PubMed ID: 11721691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levosulpiride: a review of its clinical use in psychiatry.
    Mucci A; Nolfe G; Maj M
    Pharmacol Res; 1995 Feb; 31(2):95-101. PubMed ID: 7596960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Threshold of Dopamine D2/3 Receptor Occupancy for Hyperprolactinemia in Older Patients With Schizophrenia.
    Iwata Y; Nakajima S; Caravaggio F; Suzuki T; Uchida H; Plitman E; Chung JK; Mar W; Gerretsen P; Pollock BG; Mulsant BH; Rajji TK; Mamo DC; Graff-Guerrero A
    J Clin Psychiatry; 2016 Dec; 77(12):e1557-e1563. PubMed ID: 28086010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Positron emission tomography measurement of dopamine D₂ receptor occupancy in the pituitary and cerebral cortex: relation to antipsychotic-induced hyperprolactinemia.
    Arakawa R; Okumura M; Ito H; Takano A; Takahashi H; Takano H; Maeda J; Okubo Y; Suhara T
    J Clin Psychiatry; 2010 Sep; 71(9):1131-7. PubMed ID: 20361897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hyperprolactinemia in mentally ill patients].
    Carvalho MM; Góis C
    Acta Med Port; 2011; 24(6):1005-12. PubMed ID: 22713195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroendocrine responsivities of the pituitary dopamine system in male schizophrenic patients during treatment with clozapine, olanzapine, risperidone, sulpiride, or haloperidol.
    Markianos M; Hatzimanolis J; Lykouras L
    Eur Arch Psychiatry Clin Neurosci; 2001 Jun; 251(3):141-6. PubMed ID: 11697576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.